Search

Robert G Strickley

from San Mateo, CA
Age ~63
Get Report
Also known as:
Angela Strickley, Robert Yang, Robert Stuckley
Phone and address:
198 Boothbay Ave, San Mateo, CA 94404
Related to:
Shuai Yang
Connected to:
Abbey C Strickland, 33Adela R Strickland, 56Aimee B Strickland, 54Aja Strickland, 32Alan W Strickler, 38Alanna Strickland, 57Alec D Strickland, 38Alexis A Strickling, 41Alton F Strickland, 72Alvin M Strickland, 87

Robert Strickley Phones & Addresses

  • 198 Boothbay Ave, San Mateo, CA 94404
  • 5207 Admiralty Ln, San Mateo, CA 94404
  • 801 Humboldt St, San Mateo, CA 94401
  • 1027 Foster City Blvd, Foster City, CA 94404 (650) 341-0954
  • Sacramento, CA
  • Salt Lake City, UT
  • San Francisco, CA
  • Hayward, CA
  • 1399 Parrott Dr, San Mateo, CA 94402

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Resumes

Resumes

Robert Strickley Photo 1

Senior Director

View page
Location:
1399 Parrott Dr, San Mateo, CA 94402
Work:
Pliant Therapeutics
Senior Director
Education:
University of Utah 1985 - 1989
Doctorates, Doctor of Philosophy, Philosophy
Robert Strickley Photo 2

Senior Research Scientist Ii At Gilead Sciences

View page
Position:
Senior Research Scientist II at Gilead Sciences
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Gilead Sciences
Senior Research Scientist II

Publications

Us Patents

Compounds For The Treatment Of Addiction

View page
US Patent:
8575353, Nov 5, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/791422
Inventors:
Michael Graupe - Pacifica CA, US
Juan A. Guerrero - Concord CA, US
Yafan Lu - Foster City CA, US
Robert G. Strickley - San Mateo CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Jeff Zablocki - Los Altos CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 213/62
A61K 31/47
US Classification:
546300, 514314
Abstract:
Disclosed are novel compounds having the structure of Formula (I):.

Use Of Solid Carrier Particles To Improve The Processability Of A Pharmaceutical Agent

View page
US Patent:
20090324729, Dec 31, 2009
Filed:
May 1, 2009
Appl. No.:
12/434513
Inventors:
Joanna M. Koziara - Foster City CA, US
Mark M. Menning - Foster City CA, US
Reza Oliyai - Foster City CA, US
Robert G. Strickley - Foster City CA, US
Richard Yu - Foster City CA, US
Brian P. Kearney - Foster City CA, US
Anita A. Mathias - Foster City CA, US
Assignee:
GILEAD SCIENCES, INC. - Foster City CA
International Classification:
A61K 9/30
A61K 31/5377
A61K 31/675
A61P 43/00
US Classification:
424490, 5142368, 514 81
Abstract:
The invention provides a composition comprising, a compound of formula (I):or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.

Compounds For The Treatment Of Addiction

View page
US Patent:
20130005689, Jan 3, 2013
Filed:
Jun 29, 2012
Appl. No.:
13/537536
Inventors:
Carina E. Cannizzaro - Foster City CA, US
Michael Graupe - Pacifica CA, US
Juan A. Guerrero - Concord CA, US
Yafan Lu - , US
Robert G. Strickley - San Mateo CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Jeff Zablocki - Los Altos CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/675
C07F 9/06
C07D 213/64
A61P 3/04
A61P 25/36
A61P 25/34
A61P 25/32
A61K 31/4412
A61P 25/30
US Classification:
514 89, 514351, 546 24, 546300
Abstract:
Disclosed are novel compounds having the structure of Formula (I):which are useful for treating mammals for dependence upon substances of addiction, for example addiction to a dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and/or alcohol. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formula (I) and methods of using the compounds of Formula (I) in the treatment of addiction to a dopamine-producing agent.

Compounds For The Treatment Of Addiction

View page
US Patent:
20140051668, Feb 20, 2014
Filed:
Aug 13, 2013
Appl. No.:
13/966029
Inventors:
Michael Graupe - Pacifica CA, US
Juan A. Guerrero - Concord CA, US
Yafan Lu - Foster City CA, US
Robert G. Strickley - San Mateo CA, US
Chandrasekar Venkataramani - Redwood City CA, US
Jeff Zablocki - Los Altos CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07F 9/58
C07D 213/64
US Classification:
514 89, 514351
Abstract:
Disclosed are novel compounds having the structure of Formula (I):which are useful for treating mammals for dependence upon substances of addiction, for example addiction to a dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and/or alcohol. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formula (I) and methods of using the compounds of Formula (I) in the treatment of addiction to a dopamine-producing agent.

Compositions Comprising An Rna Polymerase Inhibitor And Cyclodextrin For Treating Viral Infections

View page
US Patent:
20220280549, Sep 8, 2022
Filed:
Jan 27, 2022
Appl. No.:
17/585651
Inventors:
- Foster City CA, US
Robert G. Strickley - San Mateo CA, US
International Classification:
A61K 31/724
A61K 47/40
A61K 9/19
A61K 31/683
A61K 9/00
A61K 47/69
A61P 31/12
Abstract:
The present disclosure provides a composition comprising Compound 1, or a pharmaceutically acceptable salt thereof, cyclodextrin, and, optionally, pH adjusting agents.

Long-Acting Formulations And Vehicles

View page
US Patent:
20220265830, Aug 25, 2022
Filed:
Jul 17, 2020
Appl. No.:
17/627512
Inventors:
- Cupertino CA, US
Keith Edward BRANHAM - Pelham AL, US
James A. FILICE - Los Gatos CA, US
John W. GIBSON - Springville AL, US
John J. LEONARD - Morgan Hill CA, US
James MATRIANO - Mountain View CA, US
Whitney MORO - Birmingham AL, US
Michael SEKAR - Palo Alto CA, US
Chelsea Alexandra SNYDER - San Mateo CA, US
Robert G. STRICKLEY - San Mateo CA, US
Raju SUBRAMANIAN - San Mateo CA, US
Felix THEEUWES - Los Altos Hills CA, US
Monica TIJERINA - Foster City CA, US
Jeremy C. WRIGHT - Los Altos CA, US
Su II YUM - Los Altos CA, US
Faye XU - San Jose CA, US
Assignee:
DURECT CORPORATION - Cupertino CA
International Classification:
A61K 47/26
A61K 45/06
A61K 47/22
A61K 47/34
A61K 9/08
Abstract:
The present disclosure provides long-acting formulations and vehicles, methods of making the same and methods of using the same.

Long-Acting Formulations Of Tenofovir Alafenamide

View page
US Patent:
20220257619, Aug 18, 2022
Filed:
Jul 17, 2020
Appl. No.:
17/627000
Inventors:
- Foster City CA, US
- Cupertino CA, US
James A. Filice - Los Gatos CA, US
John W. Gibson - Springville AL, US
John J. Leonard - Morgan Hill CA, US
James Matriano - Mountain View CA, US
Whitney Moro - Birmingham AL, US
Michael Sekar - Palo Alto CA, US
Chelsea Alexandra Snyder - San Mateo CA, US
Robert G. Strickley - San Mateo CA, US
Raju Subramanian - San Mateo CA, US
Felix Theeuwes - Los Altos Hills CA, US
Monica Tijerina - Foster City CA, US
Jeremy C. Wright - Los Altos CA, US
Su Il Yum - Los Altos CA, US
Faye Xu - San Jose CA, US
International Classification:
A61K 31/675
A61K 47/26
A61K 47/34
A61K 47/22
A61P 31/18
Abstract:
The present disclosure provides long-acting formulations of tenofovir alafenamide, methods of making the same and methods of using the same.

Crystalline Forms Of Tenofovir Alafenamide

View page
US Patent:
20230091736, Mar 23, 2023
Filed:
Aug 11, 2022
Appl. No.:
17/885883
Inventors:
- Foster City CA, US
Bing Shi - Redwood City CA, US
Robert G. Strickley - San Mateo CA, US
International Classification:
C07F 9/6561
A61K 9/00
A61K 31/675
A61K 45/06
Abstract:
The present invention relates to novel crystalline forms of salts and/or co-crystals of tenofovir alafenamide, the pharmaceutical formulations, and the therapeutic uses thereof in treating viral infections.
Control profile
Robert G Strickley from San Mateo, CA, age ~63 Get Report